Stifel raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $4.00 (from $3.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Pre-Open Movers 01/03: (DRRX) (VSAR) (GPS) Higher; (OPK) (AOBC) (MCD) Lower (more...)March 2, 2018 9:28 AM After-Hours Stock Movers 03/01: (DRRX) (VSAR) (GPS) Higher; (OPK) (AOBC) (OMER) Lower (more...)March 1, 2018 6:09 PM Tandem Diabetes (TNDM) Tops Q4 EPS by 7c, Beats on Revenues; Offers FY18 Revenue Outlook Above ConsensusMarch 1, 2018 4:02 PM Tandem Diabetes Care Announces 2017 Financial ResultsMarch 1, 2018 4:00 PM